Prostate carcinoma trends in three counties in Sweden 1987-1996
- 15 March 2000
- Vol. 88 (6) , 1445-1453
- https://doi.org/10.1002/(sici)1097-0142(20000315)88:6<1445::aid-cncr24>3.0.co;2-t
Abstract
To detect changes in the incidence rate and management of prostate carcinoma, all cases of the disease diagnosed in the southeast region of Sweden between 1987–1996 were recorded. The register is based on Swedish personal registration numbers, thereby minimizing the number of dropouts. All cases of prostate carcinoma detected in the southeast region have been recorded according to a defined protocol that has been updated successively to match recent views regarding the disease. To ensure a high number of presented cases, the National Cancer Register was checked for missing cases. Six thousand seven hundred eighty-two cases of prostate carcinoma were registered in the region between 1987–1996. The age-adjusted incidence rate reached a peak in 1993, followed by a slight decrease. The mean age at diagnosis throughout the period was 74.2 years, with a peak age of 74.8 years in 1992. The number of incidental tumors followed the development of the number of transurethral resections of the prostate performed in the region, with a peak in 1991. The percentage of patients receiving gonadotropin-releasing hormone (GnRH) analogues increased from 3.9% to 37.8% whereas the percentage of patients treated with orchiectomy decreased from 40.0% to 12.8% and the percentage of those treated with radical prostatectomy decreased from 11.1% to 2.5%. A diminishing pool of latent tumors may explain the decreasing incidence rate and lower age at diagnosis observed after 1993. Orchiectomy is rapidly being superceded by GnRH analogues. In contrast to trends reported in the U.S., the percentage of men with prostate carcinoma undergoing total prostatectomy appears to be declining in Sweden. [See editorial on pages 1277–81, this issue.] Cancer 2000;88:1445–53. © 2000 American Cancer Society.Keywords
This publication has 35 references indexed in Scilit:
- Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1999
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the karolinska seriesUrology, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Trends in Prostate Cancer Survival in Sweden, 1960 Through 1988: Evidence of Increasing Diagnosis of Nonlethal TumorsJNCI Journal of the National Cancer Institute, 1996
- Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen eraUrology, 1996
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.Journal of Clinical Oncology, 1995
- Changes in prostate cancer incidence and treatment in USAThe Lancet, 1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994